The expansion signals a long-term commitment to scaling nutritional technology beyond the company’s Evanston, Illinois base. By anchoring operations in Ireland, CoreFX aims to refine how bioactive molecules are manufactured and stabilized, focusing on both shelf life and biological performance. The facility serves as a bridge for commercial growth across the European Union, utilizing Ireland’s specialized talent pool to accelerate the transition of research into market-ready products.
In section Releases
CoreFX Establishes European Innovation Hub in Ireland
Ireland’s reputation as a global nexus for food science has drawn CoreFX Ingredients to County Cork, where the biotechnology firm is opening its new European headquarters. Supported by Enterprise Ireland, the move marks a strategic shift to integrate the company’s CoreNhanced™ platform with local research expertise at Teagasc Moorepark.
Leading the scientific arm is Dr. Cara Maloney, whose background in drug delivery and biomaterials will anchor the team’s research output. Commercial operations are headed by Trevor Dunne, a veteran with two decades of international experience in the nutrition and flavor sectors. According to CEO Denis Neville, the collaboration with Teagasc Moorepark is essential to this strategy, providing a technical foundation that supports the company’s proprietary development goals. Enterprise Ireland has backed this initiative since 2023, viewing the investment as a significant endorsement of the nation's biotechnology sector.
Comments (0)
No comments yet. Be the first!